Pheton (NASDAQ:PTHL) Shares Down 3.5% – Time to Sell?

Pheton Holdings Ltd (NASDAQ:PTHL) shares were down 3.5% during mid-day trading on Monday . The stock traded as low as $0.37 and last traded at $0.3720. Approximately 22,771 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 3,792,516 shares. The stock had previously closed at $0.3855.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Pheton in a research report on Friday, October 31st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Pheton has a consensus rating of “Sell”.

Pheton Stock Down 3.5%

The business’s 50 day moving average is $0.48 and its 200-day moving average is $0.62.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Pheton stock. XTX Topco Ltd boosted its stake in Pheton Holdings Ltd (NASDAQ:PTHL) by 67.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 82,835 shares of the company’s stock after buying an additional 33,427 shares during the quarter. XTX Topco Ltd owned approximately 1.26% of Pheton worth $35,000 at the end of the most recent reporting period.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.